EU Kidney Cancer Diagnostic and Therapeutic Market, Market Segmented, by Type (Transitional Cell Cancer, Renal Cell Carcinoma, Renal Sarcoma and Others), and by Tests (Biopsy, CT Scan, Cystoscopy, Intravenous Pyelogram, and Kidney Ultrasound)- Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138239
- Pages: 200
-
Format:
Report Overview
The EU Kidney Cancer Market size stood at around USD $0.87 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Kidney cancer is one of the recurrent urologic tumors accounting for around 3% of all the human cancers. The occurrence rate of renal cell carcinoma has increased progressively in recent decades
Market Drivers and Restraints
Rise in Kidney cancer screening tests is one of the major drivers for the Kidney Cancer Diagnostics and Therapeutics market in this region. Another aspect is that European countries face comparable economic and demographic burdens and share an interest in scrutinizing their impact on health outcomes nationally and across Europe. However, the high cost of Kidney cancer treatment is one of the main factors hindering the growth of this market in this region
1. EU Kidney Cancer Diagnostic and Therapeutic Market Overview
A. Market Size
2. EU Kidney Cancer Diagnostic and Therapeutic Market Growth Drivers and Restraints
A. Rise in Kidney cancer screening test
B. The high cost of Kidney cancer treatment
3. EU Kidney Cancer Diagnostic and Therapeutic Market Segmentation
A. By Type
I. Transitional Cell Cancer
II. Renal Cell Carcinoma
III. Renal Sarcoma
IV. Others
B. By Tests
I. Biopsy
II. CT Scan
III. Cystoscopy
IV. Intravenous Pyelogram
V. Kidney Ultrasound
4. EU Kidney Cancer Diagnostic and Therapeutic Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Bayer, Company overview, Product & Services, Strategies & Financials
B. Glaxo Smith Kline, Company overview, Product & Services, Strategies & Financials
C. Sanofi, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
